Barclays
MDXH icon

Barclays’s MDxHealth MDXH Stock Holding History

Barclays’s Portfolio MDXH Stock Details MDXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7 Sell
16
-678
-98% -$910 ﹤0.01% 5305
2026
Q1 		$1.6K Buy
694
+310
+81% +$1.05K ﹤0.01% 4870
2025
Q4 		$1.37K Sell
384
-9,676
-96% -$38.2K ﹤0.01% 5071
2025
Q3 		$46.8K Buy
+10,060
New +$30.9K ﹤0.01% 4783
2023
Q1 		– Sell
-800
Closed -$5.29K – 5247
2022
Q4 		$5.29K Buy
+800
New +$5.68K ﹤0.01% 4994

Other funds holding MDXH

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $1.91M AUM 81.42% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Barclays's MDXH Position: Q2 2026 in Review

Barclays reduced its MDxHealth (MDXH) stake by 98% in Q2 2026, selling an estimated $910 and leaving 16 shares worth $7. The position accounts for ﹤0.01% of the portfolio, ranked #5305.

Barclays first reported a position in MDXH in Q4 2022 and has held it in 5 quarters since. The position peaked at $46.8K in Q3 2025. 26 funds tracked by Wall St. Rank hold MDXH as of Q2 2026.

  • Barclays held 16 shares of MDxHealth worth $7 as of Q2 2026.
  • Barclays sold 678 MDxHealth shares in Q2 2026, an estimated $910.
  • MDxHealth made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5305 holding.
  • Barclays first reported a position in MDxHealth in Q4 2022 and has held it in 5 quarters since.
  • Barclays's MDxHealth position peaked at $46.8K in Q3 2025.
  • 26 funds tracked by Wall St. Rank held MDxHealth as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.